Efficacy of Dexmedetomidine on Postoperative Analgesia

• Status: Completed
• Trial end date: 2021-09-30
• Target enrollment: 0
• Participant gender: Female

Summary

This prospective, randomized, double-blind study is designed to evaluate the postoperative analgesic efficacy of dexmedetomidine as an adjunct to ropivacaine in erector spinae block in patients undergoing radical mastectomy. The investigators hypothesis is that the administration of ropivacaine 0.5% associated with dexmedetomidine in the blockade via the plane in the erector spinae is less effective in controlling acute postoperative pain in radical mastectomy than the administration of ropivacaine 0.5% without dexmedetomidine.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Universidad autónoma de Tamaulipas
• Collaborator: Universidad Nacional Autonoma de Mexico
• Treatments: Dexmedetomidine; Ropivacaine

Criteria

Inclusion Criteria:

• Patients undergoing radical mastectomy for pathology "breast cancer"

• Patient undergoing anesthetic technique due to erector spinae plane block

• Informed consent to perform the anesthesia technique.

• Karnofsky> 80 points

Exclusion Criteria:

• Emergency surgery

• Patient with mental pathology that prevents pain assessment.

• Rejection of anesthetic technique.

• Patient with allergy to local anesthetics

• Patient with local infection of the puncture site for application of the erector spinae block